(Q44283782)

1 December 2017

title

RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines (English)

1 reference

1 December 2017

1 reference

1 reference

1 reference

Daniel P Cioca

1

1 reference

1 December 2017

Yuji Aoki

series ordinal

2

1 reference

1 December 2017

Kendo Kiyosawa

series ordinal

3

1 reference

1 December 2017

publication date

1 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

10

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

125-133

1 reference

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): a role for nautilus in embryonic somatic muscle formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Double-stranded RNA induces mRNA degradation in Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Double-stranded RNA specifically disrupts gene expression during planarian regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Silencing of developmental genes in Hydra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

21 January 2018

RNA interference--2001.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

ATP requirements and small interfering RNA structure in the RNA interference pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

RNA interference is mediated by 21- and 22-nucleotide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

RNA interference. The short answer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Inhibited apoptosis and drug resistance in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Bcl-2 targets the protein kinase Raf-1 to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Bcl-2 does not require Raf kinase activity for its death-protective function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Tyrosine kinase inhibition: an approach to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

Interfering with gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

7 January 2021

Apoptosis of human myeloid leukemia cells induced by an inhibitor of protein phosphatases (okadaic acid) is prevented by Bcl-2 and Bcl-X(L)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

7 January 2021

Independent control of cell survival by Raf-1 and Bcl-2 at the mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

7 January 2021

Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700544

1 reference

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700544

1 reference

Dimensions Publication ID

1 December 2017

1044886350

0 references

1 reference